Dysbiosis-induced SCFA depletion exacerbates MASLD progression through impaired glucagon-like peptide-1 (GLP-1) secretion, elevated intestinal permeability, and aggravated endotoxemia. Here, GCG is linked to metabolic dysfunction-associated steatotic liver disease.